Prescriptions Blog: Cholesterol Drug Sales Slip After Study
Thursday, October 20, 2011 - 14:00
in Mathematics & Economics
In the third quarter, Abbott's Niaspan failed to show the double-digit sales increases that the drug had previously generated.